Your browser is no longer supported. Please, upgrade your browser.
Settings
FLAC [NASD]
Frazier Lifesciences Acquisition Corporation
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand14.30M Perf Week1.55%
Market Cap140.86M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.01%
Income- PEG- EPS next Q- Inst Own0.22% Short Float- Perf Quarter-4.74%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.57 Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.56 - 12.39 Perf YTD-8.80%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-20.50% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low3.03% ATR0.09
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.64 Volatility0.59% 0.73%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.01 Prev Close9.79
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume17.83K Price9.85
Recom- SMA200.31% SMA50-0.27% SMA200-1.82% Volume210 Change0.61%
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.